Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
Bernadette A. M. Heemskerk-Gerritsen
Agnes Jager
Linetta B. Koppert
A. Inge-Marie Obdeijn
Margriet Collée
Hanne E. J. Meijers-Heijboer
Denise J. Jenner
Hester S. A. Oldenburg
Klaartje van Engelen
Jakob de Vries
Christi J. van Asperen
Peter Devilee
Marinus J. Blok
C. Marleen Kets
Margreet G. E. M. Ausems
Caroline Seynaeve
Matti A. Rookus
Maartje J. Hooning
机构：
[1] Erasmus MC Cancer Institute,Department of Medical Oncology
[2] Erasmus MC Cancer Institute,Department of Surgery
[3] Erasmus MC Cancer Institute,Department of Radiology
[4] Erasmus MC Cancer Institute,Department of Clinical Genetics
[5] Academic Medical Center,Department of Clinical Genetics
[6] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Epidemiology
[7] Netherlands Cancer Institute,Department of Surgery
[8] VU University Medical Center,Department of Clinical Genetics
[9] University Medical Center Groningen,Department of Surgery
[10] Leiden University Medical Center,Department of Clinical Genetics
[11] Leiden University Medical Center,Department of Human Genetics
[12] Maastricht University Medical Center,Department of Clinical Genetics
[13] Radboud University Medical Center,Department of Human Genetics
[14] University Medical Center Utrecht,Department of Medical Genetics
来源：
Breast Cancer Research and Treatment | 2019年 / 177卷
关键词：
Bilateral risk-reducing mastectomy; Prevention; Surveillance; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：723 / 733
页数：10
相关论文
共 50 条
  • [31] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [32] Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Gronwald, Jacek
    Cybulski, Cezary
    Demsky, Rochelle
    Neuhausen, Susan L.
    Kim-Sing, Charmaine
    Tung, Nadine
    Friedman, Susan
    Senter, Leigha
    Weitzel, Jeffrey
    Karlan, Beth
    Moller, Pal
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1136 - 1146
  • [33] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K.
    Gershman, S.
    Lynch, H. T.
    Ghadirian, P.
    Tung, N.
    Kim-Sing, C.
    Olopade, O. I.
    Domchek, S.
    McLennan, J.
    Eisen, A.
    Foulkes, W. D.
    Rosen, B.
    Sun, P.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
  • [34] Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers
    Rhiem, Kerstin
    Schmutzler, Rita
    BREAST CARE, 2014, 9 (06) : 385 - 389
  • [35] Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers
    Lowry, Kathryn P.
    Lee, Janie M.
    Kong, Chung Y.
    McMahon, Pamela M.
    Gilmore, Michael E.
    Chubiz, Jessica E. Cott
    Pisano, Etta D.
    Gatsonis, Constantine
    Ryan, Paula D.
    Ozanne, Elissa M.
    Gazelle, G. Scott
    CANCER, 2012, 118 (08) : 2021 - 2030
  • [36] Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
    Hagen, Anne Irene
    Maehle, Lovise
    Veda, Nina
    Vetti, Hildegunn Hoberg
    Stormorken, Astrid
    Ludvigsen, Trond
    Guntvedt, Bente
    Isern, Anne Elisabeth
    Schlichting, Ellen
    Kleppe, Geir
    Bofin, Anna
    Gullestad, Hans Petter
    Moller, Pal
    BREAST, 2014, 23 (01) : 38 - 43
  • [37] Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Gronwald, Jacek
    Robidoux, Andre
    Kim-Sing, Charmaine
    Tung, Nadine
    Lynch, Henry T.
    Foulkes, William D.
    Manoukian, Siranoush
    Ainsworth, Peter
    Neuhausen, Susan L.
    Demsky, Rochelle
    Eisen, Andrea
    Singer, Christian F.
    Saal, Howard
    Senter, Leigha
    Eng, Charis
    Weitzel, Jeffrey
    Moller, Pal
    Gilchrist, Dawna M.
    Olopade, Olufunmilayo
    Ginsburg, Ophira
    Sun, Ping
    Huzarski, Tomasz
    Lubinski, Jan
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (02) : 421 - 427
  • [38] Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
    Phillips, Kelly-Anne
    Lindeman, Geoffrey J.
    FUTURE ONCOLOGY, 2014, 10 (04) : 499 - 502
  • [39] BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma
    Blair, Alex B.
    Groot, Vincent P.
    Gemenetzis, Georgios
    Wei, Jishu
    Cameron, John L.
    Weiss, Matthew J.
    Goggins, Michael
    Wolfgang, Christopher L.
    Yu, Jun
    He, Jin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 630 - 637
  • [40] Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
    Ikejima, Kengo
    Tokioka, Sayuri
    Yagishita, Kazuyo
    Kajiura, Yuka
    Kanomata, Naoki
    Yamauchi, Hideko
    Kurihara, Yasuyuki
    Tsunoda, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (02) : 213 - 220
12345